Evaluation of Gut Microbiota in Healthy Persons and Type 1 Diabetes Mellitus Patients in North-Western Russia

Оценка кишечной микробиоты у здоровых лиц и пациентов с сахарным диабетом 1 типа на Северо-Западе России
Dmitrii E. Polev, Alexei Borisovich Chukhlovin, Дудурич Василиса Валерьевна, Кусакин Алексей Викторович, Ekaterina D. Ermachenko, Mikhail V. Aseev, Yuri A. Zakharov, Yuri A. Eismont, Lavrentii G. Danilov, Oleg S. Glotov
2023-07-15

16S rRNA sequencingBifidobacterium probioticsShannon diversity indexgut microbiotatype 1 diabetes mellitus
Bacterial microbiota in stool may vary over a wide range, depending on age, nutrition, etc. The purpose of our work was to discriminate phyla and genera of intestinal bacteria and their biodiversity within a healthy population (North-Western Russia) compared to the patients with type 1 diabetes mellitus (T1DM). The study group included 183 healthy persons 2 to 53 years old (a mean of 26.5±1.0 years old), and 41 T1DM patients (mean age 18.2±1.8 years old). The disease onset was at 11±1.5 years, with a T1DM experience of 7±1.5 years. Total DNA was isolated from the stool samples, and sequencing libraries were prepared by amplifying the V3–V4 region of the 16S rRNA gene sequenced by Illumina MiSeq. Bioinformatic processing of NGS databases was adapted for microbiota evalutaion. Despite the broad scatter, the biological diversity for bacterial microbiota expressed as the Shannon index was significantly increased from younger to older ages in the comparison group, higher in adult healthy persons, with a trend for decrease in the Actinomycetota phylum which includes Bifidobacterium longum species. Similar but non-significant age trends were noted in the T1DM group. Concordant with the Bacillota prevalence in stool samples of diabetic patients, some anaerobic bacteria (Faecalibacteria, Lachnospira and Ruminococcae, Roseburia) were enriched in the T1DM microbiome against controls. Hence, correction of microbiota for Ruminococcus and Lachnospiraceae requires future search for new probiotics. Lower abundance of Actinomycetota and Bifidobacter in T1DM suggests potential usage of Bifidobacter-based probiotics in this cohort.
1
Age-related microbiota trends were similar but not statistically significant in the type 1 diabetes group.
2
Lower Actinomycetota and Bifidobacterium abundance in type 1 diabetes supports investigating Bifidobacterium-based probiotics, while altered Ruminococcus and Lachnospiraceae warrant new probiotic research.
3
Microbiota diversity, measured by the Shannon index, increased significantly with age among healthy participants and was higher in healthy adults.
4
The study characterized gut bacterial phyla, genera, and biodiversity in 183 healthy individuals and 41 patients with type 1 diabetes in North-Western Russia using 16S rRNA sequencing.
5
Type 1 diabetes microbiota showed Bacillota prevalence and enrichment of Faecalibacterium, Lachnospira, Ruminococcaceae, and Roseburia compared with controls.

Intestinal bacterial microbiota in stool from healthy persons and patients with type 1 diabetes mellitus in North-Western Russia

Age- and T1DM-associated differences in bacterial diversity, phylum and genus composition, and the abundance of specific anaerobic bacteria

Publication Details
Publication Date
2023-07-15
Journal
Publisher
ISSN
Cited by
9
Access Type
Author Information
Authors
Dmitrii E. Polev
Alexei Borisovich Chukhlovin
Дудурич Василиса Валерьевна
Кусакин Алексей Викторович
Ekaterina D. Ermachenko
Mikhail V. Aseev
Yuri A. Zakharov
Yuri A. Eismont
Lavrentii G. Danilov
Oleg S. Glotov
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%